BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17700510)

  • 1. My friend says I should get a CA 125 test to check for ovarian cancer. Should I have this test done?
    Mayo Clin Womens Healthsource; 2007 Sep; 11(9):8. PubMed ID: 17700510
    [No Abstract]   [Full Text] [Related]  

  • 2. A doctor talks about. Screening for ovarian cancer.
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Sep; 12(1):5. PubMed ID: 15381472
    [No Abstract]   [Full Text] [Related]  

  • 3. Are there new ways to test my blood for ovarian cancer?
    Health News; 2004 Nov; 10(11):16. PubMed ID: 15655869
    [No Abstract]   [Full Text] [Related]  

  • 4. Women with symptoms of ovarian cancer should have a CA125 test, says NICE.
    Gulland A
    BMJ; 2011 Apr; 342():d2695. PubMed ID: 21525103
    [No Abstract]   [Full Text] [Related]  

  • 5. By the way, doctor. I received a widely circulated e-mail message about use of the CA-125 blood test in screening for ovarian cancer. The message suggested that the CA-125 test be used for routine screening, like a Pap smear. Do you agree? What's your opinion of this test?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Jul; 8(11):8. PubMed ID: 11511469
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?
    McGuire WP
    J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.
    Ødegaard E; Davidson B; Elgaaen BV; Fagerhol MK; Engh V; Onsrud M; Staff AC
    Am J Obstet Gynecol; 2008 Apr; 198(4):418.e1-7. PubMed ID: 18241816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer screening.
    Eason EL
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should you be screened for ovarian cancer?
    Johns Hopkins Med Lett Health After 50; 2001 May; 13(3):3. PubMed ID: 14727590
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian cancer: real progress in early detection.
    Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian cancer].
    Finnish Gynecological Association
    Duodecim; 2001; 117(22):2318-32. PubMed ID: 12183965
    [No Abstract]   [Full Text] [Related]  

  • 16. The myth of measurable disease in ovarian cancer: revisited.
    Markman M
    Cancer Invest; 2009 Jan; 27(1):11-2. PubMed ID: 19160094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative prediction of serum CA125 level in women with ovarian masses.
    Benjapibal M; Neungton C
    J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
    Camlica H; Duranyildiz D; Tas F; Yasasever V
    Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA-125 as a biomarker for malignant transformation of endometriosis.
    Check JH
    Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.